Aphios Pharma Revenue and Competitors

Claim your profile

Boston, MA USA



Total Funding



Estimated Revenue & Valuation

  • Aphios Pharma's estimated annual revenue is currently $2.6M per year.(i)
  • Aphios Pharma's estimated revenue per employee is $155,000

Employee Data

  • Aphios Pharma has 17 Employees.(i)
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation

We are leading the way in developing green, enabling biotechnology and nanotechnology drug delivery platforms and enhanced therapeutic products for health maintenance, disease prevention and the treatment of certain cancers, infectious diseases and Central Nervous System (CNS) disorders such as Alzheimer's Disease. Aphios®, which means "virus-free" in Greek, was founded in 1993 as a Delaware C corporation. The company was founded by Dr. Trevor P. Castor, President and CEO, to develop enabling technology platforms around the delivery and viral safety of biologics such as human plasma and recombinant therapeutics, hence its "virus-free" name. At its founding, the Company elected to spend about 10% of its research activities on investigating natural therapeutics. This interest has evolved to the realization that in order to solve the problems of cancer and aging, we have to look to nature, marine organisms and terrestrial plants that have learned how to control cell growth and cancerous mutation, often living for hundreds to thousands of years.



Total Funding


Number of Employees


Revenue (est)


Employee Growth %





Aphios Pharma News

2022-04-19 - Cancer Anorexia-Cachexia Syndrome Drug Market Analysis ...

Acacia Pharma Ltd, Aeterna Zentaris Inc, Aphios Corp, Incyte Corp, Lakewood-Amedex Inc, Novartis AG, Obexia AG, PsiOxus Therapeutics Ltd,...

2022-04-17 - Global Dronabinol Market SWOT Analysis, Dynamics, Drivers ...

THC Pharm; Echo Pharmaceuticals; BOL Pharma; Aphios Corporation; Benuvia Manufacturing. The study provides a thorough analysis of the global...

2022-04-17 - The Global Polymeric Nanoparticles Market is expected to grow by $ 288.43 mn during 2022-2026 progressing at a CAGR of 9.14% during the forecast period

... this report provides a detailed analysis of several leading polymeric nanoparticles market vendors that include Aphios Corp.,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding